North American Sleep-Wake Disorder Market Size to Reach $15.1 Billion by 2035

North American sleep-wake disorder market is projected to grow from $8.3 billion in 2025 and is projected to reach $15.1 billion by 2035, growing at a CAGR of 6.1% during the forecast period 2026-2035. The North American sleep-wake disorder market is experiencing steady development due to increasing clinical attention toward conditions affecting sleep quality, daytime alertness, and long-term neurological health. Healthcare providers across the region are placing greater emphasis on early diagnosis and structured treatment pathways, particularly for disorders linked with respiratory complications, stress-related conditions, and irregular sleep patterns. Growing integration of sleep medicine into primary healthcare networks has improved patient access to specialized consultations and diagnostic services. The market is also benefiting from broader adoption of home-based sleep testing systems and digitally connected monitoring technologies designed to support long-term patient management. In addition, collaborations between healthcare institutions, technology companies, and pharmaceutical developers are contributing to ongoing advancements in sleep-related therapies and diagnostic capabilities.

Browse the full report description of “North American Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/north-american-sleep-wake-disorder-market

Another important trend influencing the regional market is the increasing use of personalized treatment approaches supported by digital health platforms and data-driven clinical assessments. Medical device manufacturers and pharmaceutical companies are focusing on improving treatment adherence through connected devices, remote monitoring systems, and patient-centric therapy solutions. Sleep clinics and healthcare organizations are also expanding telehealth services to support follow-up care and improve accessibility in remote and underserved areas. The growing use of wearable health technologies for sleep tracking and behavioral monitoring has further strengthened interest in preventive sleep healthcare. Regulatory support for innovative therapeutic technologies and continuing research activities related to neurological and respiratory disorders continue to shape the evolving market environment across North America.

Competitive Landscape of the Sleep-Wake Disorder Market

The key players in the sleep-wake disorder market are ResMed Inc., Inspire Medical Systems Inc., Harmony Biosciences Holdings Inc., Eli Lilly and Company, and Jazz Pharmaceuticals plc., among others. Industry participants are focusing on expanding therapeutic and diagnostic capabilities through advancements in respiratory support systems, neurostimulation therapies, and prescription-based sleep disorder treatments. Ongoing investments in digital monitoring platforms, home-based diagnostic technologies, and personalized treatment approaches are influencing competitive developments across the market. Companies are also strengthening clinical research activities and regulatory engagement to support broader adoption of next-generation sleep management solutions. Strategic collaborations with healthcare providers and technology firms continue to contribute to innovation within the evolving treatment landscape.

• In December 2025, ResMed Inc. received U.S. FDA clearance for its AI-enabled Personalized Therapy Comfort Settings technology, marketed as Smart Comfort. The solution was designed to personalize CPAP therapy settings for obstructive sleep apnea patients using machine learning and real-world sleep data. The company announced plans for an early 2026 limited U.S. rollout integrated with its AirSense 11 platform and myAir application ecosystem.

• In February 2025, Harmony Biosciences Holdings Inc. continued expanding its North American sleep-wake disorder portfolio through investments in orexin-based therapies and broader neurological pipeline development. The company highlighted the ongoing advancement of its sleep/wake development programs and increased research spending associated with newly licensed and acquired therapeutic assets. This strategic expansion reflected growing industry focus on next-generation therapies targeting narcolepsy and excessive daytime sleepiness disorders. The company’s activity also demonstrated rising pharmaceutical investment in differentiated sleep-wake treatments beyond traditional stimulant-based approaches.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Disorder Type
  • By Treatment Type
  • By Diagnosis & Management Approach
  • By Application
• Competitive Landscape - ResMed Inc., Inspire Medical Systems Inc., Harmony Biosciences Holdings Inc., Eli Lilly and Company, and Jazz Pharmaceuticals plc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

North American Sleep-Wake Disorder Market Report Segment

By Disorder Type

• Insomnia
• Hypersomnia
• Sleep Apnea
• Circadian Rhythm Sleep-Wake Disorders
• Parasomnias
• Dyssomnias
• Others

By Treatment Type

• Pharmacological Therapy
• Behavioral Therapy
• Light Therapy
• Device-Based Therapy
• Others

By Diagnosis & Management Approach

• Polysomnography & Sleep Studies
• Actigraphy-Based Monitoring
• Clinical Evaluation & Screening Tools
• Remote / Digital Sleep Monitoring Solutions

By Application

• Hospitals
• Home Care Settings
• Others

North American Sleep-Wake Disorder Market Report Segment by Country

• United States
• Canada

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-sleep-wake-disorder-market